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Lomeﬂoxacin (LFLX) is phototoxic and phototumorigenic, but the mechanisms of phototumorigenesis of quinolone
drugs have not been fully elucidated. Formation of cyclobutane pyrimidine dimers (CPD) by UVB radiation is
primarily involved in the carcinogenesis of ultraviolet (UV) radiation. On the other hand, UVA region is responsible
to photobiologic reactions of quinolone drugs. To know if CPD can be formed by UVA radiation in the presence of
LFLX and is involved in the phototumorigenesis, we used xeroderma pigmentosum (XP) group A gene-deﬁcient
(XPA(/)) mouse, which is defective in nucleotide excision repair. XPA(/) and XPA(þ /þ ) mice were irradiated
to 5 J per cm2-UVA with or without the administration of LFLX. In XPA(/) mice treated with LFLX, the ﬁrst skin
tumor appeared after exposures to 75 J per cm2 in 5 wk. In XPA(þ /þ ) mice treated with LFLX, the ﬁrst tumor
appeared after exposures to 345 J per cm2 in 23 wk. Immunohistochemically, CPD formation was observed after
UVA-exposure in the skin of XPA(þ /þ ) as well as XPA(/) mice which had been given LFLX. The CPD disap-
peared, however, earlier from XPA(þ /þ ) mice than from XPA(/) mice. The acute inﬂammatory reaction after
LFLX administration and exposure to UVA were greatly enhanced in XPA(/) mice. These results indicate that
UVA exposure induces DNA damage in the form of CPD in the presence of LFLX, which exerts phototoxicity and
phototumorigenesis.
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Exposure to sunlight is widely accepted as a critical caus-
ative factor in the pathogenesis of skin cancers. The DNA
damage induced by ultraviolet (UV) radiation appears to be
an important molecular trigger for non-melanoma skin can-
cers. It is well established that the responsible spectrum for
the sunlight-induced skin cancers is primarily in UVB region,
which efficiently produces cyclobutane pyrimidine dimers
(CPD) formation. Whereas CPD are experimentally detect-
able in human skin after exposure to UVA, CPD yields are
much smaller than those for UVB (Freeman et al, 1985,
1987; Schothorst et al, 1985), because UVA wavelengths
are hardly absorbed by DNA. In contrast, UVA range can
indirectly generate oxidative DNA lesions, such as 8-hydro-
xy-20-deoxyguanosine (8-OHdG) (reviewed by Ru¨nger,
1999). Furthermore, it has been shown experimentally that
not only UVB but also UVA portion can be mutagenic (Wells
and Han, 1984; Jones et al, 1987; Drobetsky et al, 1995) and
carcinogenic (van Weelden et al, 1988; Matsui and DeLeo,
1991; de Gruijl et al, 1993). Among UV-induced DNA dam-
ages, CPD and pyrimidine-pyrimidone (6–4) products are
crucially involved in mutagenesis and carcinogenesis (Set-
row, 1966; Moan and Peak, 1989; Hart et al, 1997). The
formation and removal of these DNA photoproducts have
been extensively investigated in rodents and human both in
vitro and in vivo systems and it has been demonstrated that
normal human cells exhibit rapid repair (Taichman and Set-
low, 1979; Muramatsu et al, 1992). But, repeated exposures
to sunlight can induce errors in repair of DNA damages
which are associated with mutations in oncogenes and
tumor suppression genes and can result in the initiation of
skin cancers (Ziegler, 1993).
Some of photoreactive chemicals can also trigger cuta-
neous reactions even with exposure to normally harmless
doses of sunlight. The second generation of fluoloquinolone
antibiotics, which are chemically related to nalidixic acid
(NA), have been widely used for the treatment of a broad
spectrum of infectious disease. Their mechanism of anti-
bacterial action is depend on the ability to inhibit the bac-
terial gyrase, an enzyme associated with DNA replication,
recombination, and repair (Shen and Pernet, 1985; Shen
et al, 1989). The phototoxic and photoallergic potential of
these chemicals has been extensively examined clinically
and experimentally (Burry, 1974; Wagai et al, 1990; Horio
et al, 1994; Klecak et al, 1997). Previous reports suggested
that the mechanism of their phototoxicity was most likely
initiated by the generation of reactive oxygen species (ROS)
in the target tissue, especially hydroxyl radicals. Wagai and
Tawara (1992) reported that phototoxic ear-swelling re-
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sponse in mice to quinolones after UVA exposure was
prevented almost completely by the pretreatment with
butylated hydroxytoluene, a free radical scavenger. Lome-
floxacin (LFLX), a quinolone antibacterial agent, has been
shown to be phototumorigenic in mouse skin (Johnson et al,
1997; Klecak et al, 1997; Urbach, 1997). It has not yet been
elucidated, however, which type of DNA lesions is mainly
involved in photocarcinogenesis because of LFLX and UVA
radiation. Recently, it was reported that UVA irradiation after
LFLX administration was able to induce pyrimidine dimer
formation in human skin cells (Traynor and Gibbs, 1999).
Then, in the present study, we used the xeroderma pig-
mentosum group A (XPA)(/) mice, which are defective in
nucleotide excision repair. The mice closely simulate human
patients with xeroderma pigmentosum (XP) who have an
extremely high risk of developing sunlight-induced skin
cancers (Kraemer et al, 1994). Previously we have demon-
strated that XPA(/) mice easily develop acute inflamma-
tion and skin cancers after UVB irradiation (Nakane et al,
1995). If CPD formation is primarily associated with LFLX-
photocarcinogenesis, higher incidence of skin tumors must
be observed in XPA(/) mice than XPA(þ /þ ) mice after
the LFLX-UVA treatment. Although the photocarcinogenesis
of other quinolone antibiotics have not been known, of-
loxacin and NA were also examined as these compounds
have acute phototoxicity.
Results
LFLX showed stronger phototoxicity in XPA(/) mice
than in XPA(þ /þ ) mice The ear swelling response
to quinolones after 5 J per cm2-UVA radiation is shown in
Fig 1. XPA(/) mice developed much stronger ear swelling
after receiving LFLX and UVA irradiation than XPA(þ /þ )
mice. The phototoxic reaction reached a maximum 48 h
after irradiation. In contrast, ofloxacin (OFLX) did not show
phototoxicity after exposure to UVA at a dose of 5 J per cm2
either in XPA(/) or XPA (þ /þ ) mice.
Photocarcinogenesis of LFLXwas enhanced in XPA(/)
mice In XPA(/) mice with LFLX-administration, the first
skin tumor appeared in 5 wk after exposure to UVA at a
cumulative dose of 75 J per cm2. On the other hand, in
XPA(þ /þ ) mice with LFLX-administration, the first skin
tumor appeared in 23 wk after exposure to UVA at a cumu-
lative dose of 345 J per cm2, when approximately three
tumors per one animal had developed in XPA(/) mice
(Fig 2). Thereafter, some of the XPA(/) mice died with
multiple large tumors. After the completion of 26 wk treat-
ment, new tumors appeared in XPA(þ /þ ) mice although
only one tumor per mouse was found at the end of the ob-
servation period, 30 wk. The size of tumors was larger in
XPA(/) than in XPA(þ /þ ) mice (Fig 3). Histologically, the
majority of skin tumors were squamous cell carcinomas
(SCC). Skin tumor did not develop after UVA irradiation with
or without administration of OFLX or NA in XPA(/) or
XPA(þ /þ ) mice.
CPD is formed by LFLX and UVA but not repaired in
XPA(/) mice Immunohistochemically, CPD formation
was detectable 1 h after UVA-exposure in the skin of
XPA(þ /þ ) and XPA(/) mice which had been given LFLX.
The CPD disappeared 48 h after irradiation from XPA(þ /þ )
mice, whereas CPD-bearing cells remained unaltered in
XPA(/) mice (Fig 4). UVA irradiation without LFLX ad-
ministration did not induce CPD formation. Moreover, CPD
formation was not observed after UVA-exposure in the skin
of XPA(þ /þ ) and XPA(/) mice which had been given
OFLX and NA(data not shown).
Oxidative DNA damage and (6–4) photoproduct were not
detected after UVA irradiation with or without LFLX
administration Immunofluorescence staining for 8-OHdG
and (6–4) photoproduct revealed no positive cells 1 h after
irradiation in the skin of XPA(/) and XPA(þ /þ ) mice
which had been exposed to 5 J per cm2 UVA with or without
LFLX administration.
Figure1
Ear swelling response to quinolone phototoxicity. Ears of xeroder-
ma pigmentosum group A (XPA)(þ /þ ) and XPA(/) mice were ex-
posed to 5 J per cm2 of UVA 1 h after oral administration of LFLX (0.5
mg) or OFLX (0.6 mg). Ear thickness was measured immediately before
and 1, 2, 3, and 4 d after irradiation. Data are expressed as mean
intensity of ear swelling (  SD) in three mice (six ears). po0.01 com-
pared with XPA(þ /þ ) mice exposed to LFLX plus UVA. XPA,
xeroderma pigmentosum group A; UV, ultraviolet; LFLX, lomefloxacin;
OFLX, ofloxacin.
Figure2
Photocarcinogenesis of LFLX was enhanced in XPA(/) mice.
LFLX (0.5 mg) was given orally 1 h before UVA (5 J per cm2) exposure.
The treatment was performed three times a week for 26 wk. The cu-
mulative dose was 390 J per cm2. The appearance and development of
tumors were checked weekly. Data are expressed as mean number of
tumors per mouse larger than 3 mm (  SD) in diameter of 10 mice in
each group. po0.01 compared with XPA(þ /þ ) mice. XPA, xeroder-
ma pigmentosum group A; UV, ultraviolet; LFLX, lomefloxacin.
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Sunburn cell (SBC) formation by LFLX and UVA is en-
hanced in XPA(/) mice Oral administration of LFLX and
subsequent exposure to UVA produced SBC in a concen-
tration-dependent manner in the epidermis. The number of
SBC was much higher 1 h after irradiation in XPA(/) than
XPA(þ /þ ) mice 24 h after irradiation at any dose examined
(Fig 5). UVA irradiation up to 20 J per cm2 without LFLX
produced no SBC. SBC were not formed after UVA expo-
sure in the mice which had been given OFLX and NA.
Discussion
The mechanism whereby photoreactive compounds exert
their reaction is complex and still not completely elucidated.
Photosensitizers can be categorized by their oxygen
requirement into oxygen-dependent (photodynamic) and
oxygen independent compounds. In regard to the photo-
sensitivity reaction of fluoloquinolone, photodynamic, and
non-photodynamic actions have been proposed. To know
the mechanism of photocarcinogenesis of LFLX, we
attempted to induce skin cancers by UV exposures in
XPA(/) mice. The mice were generated by XPA-gene
targeting, and therefore have the defect in excision repair of
pyrimidine dimers but have the ability to repair of oxidative
DNA damages as well as their wild littermates. The present
study demonstrated that LFLX can exert its photocarcino-
genetic ability after exposure to a small amount of UVA ra-
diation. In control XPA(þ /þ ) mice, the first tumor appeared
in 23 wk after LFLX and UVA exposures. Klecak et al ob-
served earlier the first tumor in 16 wk in SKh-1 mice which
had received repeated treatments with LFLX (0.5 mg) and
UVA (25 J per cm2) five times every 2 wk. In our exper-
iments, the mice were exposed to UVA at a dose of 5 J per
cm2 three times a week, because XPA(/) mice develop
severe phototoxic reactions to higher doses of UVA after
LFLX (0.5 mg) administration. The tumorigenicity of LFLX
was also greatly enhanced in XPA(/) mice which are de-
fective in the excision repair of CPD lesions in DNA, devel-
oping a large number and size of SCC in a short period, 5
wk. Immunohistochemical examinations revealed that CPD
was actually formed after LFLX and UVA exposure and was
not repaired in XPA(/) mice. On the other hand, oxidative
damage of DNA, 8-OHdG-positivity, was not detected after
UVA irradiation with or without LFLX administration in this
study. Although UVB exposure induced oxidative DNA
damage in the skin, there was no difference in its forma-
tion between XPA(/) and XPA(þ /þ ) mice (unpublished
data). These observations indicate that CPD formation is
Figure 3
Representative mice which developed squamous cell carcinoma at
23 wk after the treatments with oral LFLX and UVA irradiation. The
size of tumor was much larger in XPA(/) mice than in XPA(þ /þ )
mice. XPA, xeroderma pigmentosum group A; UV, ultraviolet; LFLX,
lomefloxacin.
Figure 4
LFLX and subsequent UVA exposure induced CPD formation. The
immunofluorescence of CPD staining was observed at 1 h after UVA
exposure in the skin of XPA(þ /þ ) and XPA(/) mice (arrows). CPD
disappeared from XPA(þ /þ ) at 48 h, whereas remained in XPA(/)
mice (arrows). Scale bar¼50 mm. XPA, xeroderma pigmentosum group
A; UV, ultraviolet; LFLX, lomefloxacin; CPD, cyclobutane pyrimidine
dimers.
Figure5
The induction of sunburn cells by LFLX and UVA was enhanced in
XPA(/) mice. Biopsy specimens were taken 24 h after irradiation
with 5, 10, or 20 J per cm2. The number of sunburn cells was counted in
five Hematoxylin and eosin-stained sections. Data are expressed as
mean number of sunburn cells (  SD) per 1 cm of the epidermis.
po0.01 compared with XPA(þ /þ ) mice. XPA, xeroderma pigmento-
sum group A; UV, ultraviolet; LFLX, lomefloxacin.
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importantly involved in the photocarcinogenesis of LFLX.
Previously it was demonstrated that LFLX photosensitized
pyrimidine dimmer formation in human skin cells. As a pos-
sible mechanism for this effect, a triplet–triplet energy
transfer was proposed (Traynor and Gibbs, 1999). In brief,
after absorption of photon, LFLX may transfer energy from
its triplet (3LFLX) to ground-state singlet pyrimidine (1Pyr)
to form pyrimidine dimmer (Pyro4Pyr):
3LFLXþ1Pyr!1 LFLXþ3Pyr;
3Pyrþ1Pyr! Pyr < > Pyr:
When a photoreactive compound is genotoxic, it is likely to
be capable of inducing photomutagenesis and tumor initi-
ation. The capability of phototumorigenesis of fluoroquino-
lone antibiotics has been previously reported in animal
experiments (Johnson et al, 1997; Klecak et al, 1997;
Ma¨kinen et al, 1997). Among the drugs examined, only LFLX
caused the development of SCC. Animals exposed to UVA
after administrations with fleroxacin, ciprofloxacin, OFLX, or
NA developed benign skin tumors such as papilloma,
keratoacanthoma, or solar keratosis but a few SCC. The
reason why there is the difference in photocarcinogenic
ability among fluoroquinolones has not been clearly ex-
plained. Klecak et al (1997) demonstrated that there were no
such differences in skin concentrations after oral adminis-
trations among quinolone antibiotics. The photocarcino-
genesis of OFLX and NA may be weak, possibly because
these chemicals do not form CPD after UVA irradiation.
LFLX, when exposed to UVA radiation, could generate
ROS (Wagai and Tawara, 1992; Martinez et al, 1998), and
induce oxidative damage to DNA (Rosen et al, 1997; Verna
et al, 1998). Therefore, LFLX combined with UVA irradiation
can induce at least two types of DNA damages, CPD and
oxidative damage, which could lead to mutation and tumor
initiation. The present study suggested that CPD lesion
plays more important role than oxidative damage in the
photocarcinogenesis, because XPA(/) mice, which
showed greatly enhanced cancer development, are defec-
tive only in nucleotide excision repair. The production of
ROS, oxidative DNA damage and repair might occur in
XPA(/) as well as XPA(þ /þ ) mice. In addition, the pho-
totoxic reaction of LFLX was also enhanced in XPA(/)
mice, indicating that the CPD formation but not oxidative
damage may be mainly responsible for the phototoxicity of
fluoroquinolones. Previously quinolones were reported to
exert their phototoxic abilities by producing ROS. The pho-
totoxicity of drugs, however, is not necessarily correlated
with the efficiency of photosensitized production of ROS
(Martinez et al, 1997; Umezawa et al, 1997) or oxidative
DNA damage by drugs (Sauvaigo et al, 2001).
Solar radiation not only acts as carcinogen, but also in-
duces specific suppression within the cutaneous immune
system. The immunosuppressive effects of UVB as well as
its mutagenic properties, may contribute to the mecha-
nisms of sunlight-induced skin cancer. The most possible
candidate molecule that initiates UVB-induced immuno-
suppression is epidermal DNA (Kripke et al, 1992; Vink et al,
1997). We have previously confirmed that UVB- and chem-
ical carcinogen-induced immunosuppression is enhanced
in XPA(/) mice associated with hyperproduction of
immunosuppressive factors such as prostaglandin E2,
tumor necrosis factor-a and interleukin-10 (Miyauchi-Hashi-
moto et al, 1996, 2001; Kuwamoto et al, 2000). Conse-
quently, it is also reasonable to speculate that LFLX plus
UVA may induce immunosuppression, and accelerate the
photocarcinogenesis by similar mechanisms. This is under
current investigation.
Previously we have reported that the UVB radiation with-
out photoreactive chemicals can easily produces SCC in
XPA(/) mice (Nakane et al, 1995). In the present exper-
iments, SCC also developed from the epidermal keratin-
ocytes but no tumors from the dermal cells after LFLX and
UVA irradiation. The UVA wavelengths penetrate deeper
into the dermis than UVB. Marrot et al (2003), however,
demonstrated that keratinocytes were more sensitive to the
LFLX photosensitization of DNA than melanocytes and
fibrocytes.
In conclusion, the enhancement of phototoxicity and photo-
carcinogenesis of LFLX after UVA irradiation in XPA(/)
mice strongly suggested that CPD formation is mainly as-
sociated with these photobiological reactions. But, the pos-
sibility cannot be completely excluded that DNA lesions
other than CPD are induced by LFLX-UVA, and that these
lesions could also be targeted by nucleotide excision repair.
It is of note that not only UVB but also UVA radiation could
effectively induce CPD lesions in the presence of photore-
active substances. Although fluoroquinolone antibiotics are
usually given for short-term use, it may be advisable not to
prescribe the drugs to patients with DNA repair deficiencies
especially XP. The experimental system utilized XPA(/)
mice could be a time-consuming and less-expensive assay
to predict the photocarcinogenic drugs.
Materials and Methods
Animals The XPA gene-deficient mice with CBA, C57BL/6, and
CD-1 chimeric background were backcrossed with hairless albino
mice of the inbred strains Hos/HR-1, and the resultant hairless
XPA(/) and (þ /þ ) mice were used in these studies. The animals
were housed in specific pathogen-free, air-conditioned rooms with
a temperature of 22(  2)1C, relative humidity of 55(  10)% and a
dark–light cycle of 12 h. These mice were 6–12 wk of age at the
beginning of each experiment. Each experimental panel consisted
of 10 mice. Animal experiments were approved by the Kansai
Medical University Subcommittee on Research Animal Care.
Drugs Quinolones tested include LFLX, ofloxacin, and NA.
UVA irradiation The light source was a bank of 14 fluorescent
black lights (FL32.BL; Toshiba Medical Supply, Tokyo, Japan) with
an emission spectrum of 300–430 nm peaking at 352 nm. The mice
were exposed to UVA radiation through a pane of glass. The ir-
radiance was measured by a radiometer, UVR/305/365D(II) (Tosh-
iba Medical Supply).
Induction of tumors The test compounds were orally adminis-
tered by gavage using a standard vehicle that contained sodium
carboxymethyl cellulose 1 h before UVA-irradiation. The drug dos-
es were determined based on the previous report (Klecak et al,
1997) as follows: LFLX, 0.5 mg; ofloxacin, 0.6 mg; NA, 0.1 mg per
mouse. XPA(/)mice and XPA(þ /þ ) mice were irradiated to
dose of 5 J per cm2-UVA three times a week with or without drugs
for 26 wk.
Ear swelling response LFLX (0.5 mg) or ofloxacin (0.6 mg) was
orally administrated to the mice. After 1 h, the ears of XPA(þ /þ )
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and XPA(/) mice were exposed once to UVA at a dose of 5 J per
cm2. Ear thickness as an acute inflammation was measured with a
dial thickness gauge (Peacock, Tokyo, Japan) immediately before
and 1, 2, 3, and 4 d after UV irradiation. Ear swelling represented
an increment in thickness above the value before irradiation.
Immunohistochemical examination The staining procedure for
CPD has been previously described in detail (Horiki et al, 2000). In
brief, skin sections (5 mm) were air-dried and DNA was denatured.
The sections were incubated 30 min in 1% newborn calf serum.
They were stained with CPD monoclonal anti-mouse IgG (diluted at
1:50) antibody for 1h and stained with goat-mouse IgG fluorescein
isothiocyanate (diluted at 1:50) for 1h. Immunofluorescence stain-
ing was also performed to detect the formation of the oxidative
DNA damage and (6–4) photoproduct using the monoclonal anti-
body to 8-OHdG and (6–4) photoproduct.
Histological examination and SBC counting The dorsal area of
mice was exposed to UVA at a dose of 5, 10, or 20 J per cm2 after
LFLX administration. Biopsy specimens were taken 24 h after
irradiation and processed histologically and stained with hem-
atoxylin and eosin. Histologic changes were observed, and the
number of SBC in the interfollicular epidermis was counted in three
different sections under a  10 ocular lens and grid. The average
number of SBCs per section was calculated.
Tumor counting and histological examination of tumors The
number of tumors was counted on the dorsal area. The presence
and progression of skin tumors were checked weekly. The number
of all tumors and the number of tumors larger than 3 mm in di-
ameter were recorded. Skin tumors were biopsied, and tissue
sections were stained with hematoxylin and eosin for histological
examinations of malignant changes.
Statistics The Student’s t test was used to determine the statis-
tical significance of data.
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